SANUWAVE Health, Inc. announced the appointment of Dr. Tom Price to its Board of Directors.  Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE.  Dr. Price’s extensive experience in public service, serving the state of Georgia in the statehouse followed by 12 years in the House of Representatives, brings a board perspective that shall greatly enhance the profile and value of SANUWAVE’s Board of Directors. 

“We are delighted to welcome Dr. Price to our Board of Directors,” said Kevin A. Richardson II, CEO and Chairman of the Board of Directors of SANUWAVE Health, Inc. “Tom’s experience and background will prove invaluable as a board member as we continue to grow and expand as a company.  We look forward to his strategic insights and guidance as we navigate this rapid growth and the challenges that come with it in the coming years,” concluded Mr. Richardson.

Dr. Price holds a BA and MD from the University of Michigan and completed his residency in orthopedic surgery at Emory University in Atlanta.  He entered private practice in 1984 and returned to Emory as an assistant professor in of orthopedic surgery in 2002.  He was director of the orthopedic clinic at Atlanta’s Grady Memorial Hospital.  Dr. Price’s political career began as a Member of the Georgia Senate from the 56th district from 1996 to 2005, he was the minority Whip from 1998 to 2002, and the Majority leader of the Georgia Senate from 2002 to 2003.  He served in the US House of Representatives from Georgia’s 6th district from 2005 to 2017, during which time he served as Chair of the House Budget Committee from 2015 to 2017.  In February 2017 he was confirmed by the Senate as the United States Secretary of Health and Human Services (HHS) and remained in that position until September 2017.  Currently Tom serves on the boards of several privately held health care companies and non-profits as well as consulting and advising companies. 

Commenting on his appointment, Dr. Price stated, “I am very excited to join SANUWAVE’s Board of Directors at this point in time when they are entering the commercialization phase with such rapid growth.  I am impressed with SANUWAVE’s commitment in research and development and clinical trials to treating cumbersome medical conditions.  Diabetes afflicts millions of Americans and even more globally.  The dermaPACE System for treating Diabetic Foot Ulcers (DFUs) is a novel and effective treatment to help improve the quality of life for diabetic patients.  I am especially impressed and ready to assist the team achieve their goal of having a device placed anywhere and everywhere a DFU is treated.”